Puma Biotechnology Inc (PBYI) — Capital Reinvestment Ratio
Puma Biotechnology Inc (PBYI) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.42 Million) in capital expenditures ($36.00K). See Puma Biotechnology Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Puma Biotechnology Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Puma Biotechnology Inc's Capital Reinvestment Ratio across 6 annual periods. Check PBYI total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Puma Biotechnology Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Puma Biotechnology Inc from 2019 to 2025. For live market cap and broader valuation context, see Puma Biotechnology Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $41.80 Million | $71.00K | ▲ +18.0% |
| 2024 | 0.00x | $38.92 Million | $56.00K | ▼ -99.7% |
| 2023 | 0.47x | $27.01 Million | $12.64 Million | ▲ +966303.8% |
| 2021 | 0.00x | $20.65 Million | $1.00K | ▼ -100.0% |
| 2020 | 25.06x | $800.00K | $20.05 Million | ▲ +183130.9% |
| 2019 | 0.01x | $22.38 Million | $306.00K | — |